STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
17 hedge funds and large institutions have $456K invested in Statera Biopharma, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$29K | |
| 2 | +$21K | |
| 3 | +$16K | |
| 4 |
Renaissance Technologies
New York
|
+$3.74K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1K |